INTRODUCTION {#rjx218s5}
============

Each year 15% of patients on the UK liver transplant waiting list either die or been removed \[[@rjx218C1]\]. One strategy to increase organ availability is splitting, performed either *in situ* or *ex situ*. The most common approach is the 'classical' left lateral + right trisegmentectomy split. The less frequently performed full left-right split can provide livers for two adults but this is technically complex and questions remain over vascular and biliary outcomes \[[@rjx218C2]\].

Normothermic machine perfusion of the liver (NMP-L) was developed to attenuate IRI and improve organ utilization: early data validated by transplantation \[[@rjx218C3], [@rjx218C4]\] are encouraging. Here, we report viability testing and resuscitation of a donor liver followed by splitting with concurrent NMP-L.

CASE REPORT {#rjx218s6}
===========

Donor {#rjx218s6a}
-----

A 69-year-old female DCD liver, BMI 34.3 kg/m^2^, DRI 3.053, with a hypoxic brain injury and a 7-day ITU admission, was initially accepted for transplantation. Withdrawal of life-sustaining treatment was conducted according to UK standard practice and 34 min later dual arterial and porto-venous perfusion commenced with 4°C UW solution, using the super-rapid technique. The liver was mildly steatotic with an iatrogenic 2.5 cm left lobe laceration and atherosclerotic arteries.

CIT was 9 h 43 min. It was subsequently declined for transplantation and subjected to NMP-L. The donor consented to research and NMP-L was approved by London-Surrey Borders National Research Ethics Service committee (13/LO/1928).

NMP-L {#rjx218s6b}
-----

The liver was prepared for modified piggyback transplantation. NMP-L commenced with a packed red cell (PRC) based fluid at 37°C using the Liver Assist device (Organ Assist, The Netherlands) via hepatic artery and portal vein cannulae. Oxygenated pulsatile flow (pressure 50 mmHg) and non-pulsatile flow (pressure 10 mmHg) perfused the liver via hepatic artery and portal vein, respectively, before recirculating via the open circuit reservoir.

During NMP-L, flow parameters, blood gases and bile production were assessed every 30 min. Homogenous perfusion, stable flow parameters, lactate \< 2.0 mmol/L and evidence of bile production after 2 h fulfilled criteria for viability.

Splitting {#rjx218s6c}
---------

'Classical' left lateral + right trisegmentectomy split was performed with an integrated bipolar/ultrasonic device (Thunderbeat, Olympus, UK) for dissection with simultaneous ligation. Splitting was conducted in the reservoir with concurrent NMP-L throughout (Fig. [1](#rjx218F1){ref-type="fig"}A and B, and video), maintaining inflow and outflow for both 'grafts'.

![Splitting of DCD liver with concurrent NMP-L. (**A**) Appearance of the right lobe of liver after parenchymal transection whilst continuing NMP-L. (**B**) Appearance of liver lobes on completion of splitting and NMP-L.](rjx218f01){#rjx218F1}

Flow parameters and perfusate analysis were recorded throughout splitting from left and right hepatic arteries, portal veins and IVC. Post-procedure blood flow was confirmed using Doppler ultrasound (CX50 CompactXtreme, Philips, The Netherlands), in each lobe.

Histology {#rjx218s6d}
---------

Specimens taken 3 hourly and on completion of NMP-L from each lobe were examined by H&E and PAS staining. Blinded assessment was performed by a pathologist.

RESULTS {#rjx218s7}
=======

Pre-splitting {#rjx218s7a}
-------------

The liver weighed 1650 g. Duration of pre-splitting NMP-L was 6 h 28 min. Commencing NMP-L, arterial and portal venous flow rates were 116 and 630 mL/min, respectively, reaching 573 and 1500 mL/min after 3 h (Fig. [2](#rjx218F2){ref-type="fig"}A): physiological pressures were maintained. Vascular resistance remained low. Initial temperature was 26°C, reaching 36°C after 47 min. Prior to NMP-L, lactate concentration was \> 20.0 mmol/L and after 2 h lactate was 1.0 mmol/L (Fig. [2](#rjx218F2){ref-type="fig"}B), with 11 g of bile being excreted (Fig. [2](#rjx218F2){ref-type="fig"}C).

![Characteristics of the liver subjected to NMP-L prior to splitting. (**A**) Hepatic arterial and portal venous flow rates; (**B**) lactate concentrations; (**C**) cumulative bile production; and (D) glucose concentrations.](rjx218f02){#rjx218F2}

Parenchymal transection {#rjx218s7b}
-----------------------

Duration of splitting with concurrent NMP-L was 71 min (total duration 8 h 22 min). Haemostasis was maintained, no additional PRC were required, suction devices were not used.

After parenchymal splitting and maintaining differential pressures (median 54 \[54--55\] mmHg), total hepatic arterial flow remained just below pre-hilar rates (median 429 \[424--450\] mL/min). Total portal venous flow rate increased to near pre-splitting rates (median 1250 \[1230--60\] mL/min) whilst maintaining physiological pressures (median 9 \[8--10\] mmHg).

Post-hilar phase lactates were similar in both hepatic arteries, portal veins and IVC (Table [1](#rjx218TB1){ref-type="table"}). Post-parenchymal phase lactate was unchanged. IVC Lactate increased by 0.3 mmol/L compared to the pre-hilar phase. Bile production continued throughout. Doppler ultrasound demonstrated expected hepatic arterial, portal venous and IVC waveforms in both lobes after splitting (Fig. [3](#rjx218F3){ref-type="fig"}). Table 1Table of flow rates and blood gas results prior to, during and after completion of splitting with concurrent NMP-L.Pre-parenchymal, post-hilar dissectionPost-parenchymal TransectionLeftRightIVCLeftRightIVCHAPVHAPVHAPVHAPVpH7.4397.4327.4427.4487.3877.4167.4057.4397.4037.369pCO~2~ (kPa)4.044.224.104.064.833.964.293.744.324.93pO~2~ (kPa)10.076.809.477.024.677.945.8310.216.283.48BE (mmol/L)−3.6−3.2−3.1−2.9−3.3−5.2−4.5−4.9−4.4−4.0HCO~3~^−^ (mmol/L)20.020.620.520.621.318.719.718.619.820.9tHb (g/L)76.578.276.777.581.078.178.479.579.076.1Hct (%)17.217.617.617.418.316.617.016.817.016.8Glucose (mmol/L)13.714.014.113.814.415.315.816.615.815.6Lactate (mmol/L)2.72.72.82.62.62.62.72.82.72.9

![Representative Doppler ultrasound images of parenchyma from liver split with concurrent NMP-L. (**A**) Hepatic arteriolar waveform; (**B**) portal venous waveform; and (**C**) hepatic venous waveform.](rjx218f03){#rjx218F3}

Histology {#rjx218s7c}
---------

Moderate sinusoidal vasodilatation was noted throughout although milder post-splitting (Fig. [4](#rjx218F4){ref-type="fig"}A, C, E and G). There were no necrotic hepatocytes post-splitting (Fig. [4](#rjx218F4){ref-type="fig"}G). Macrovesicular steatosis was low (\< 10%) pre-NMP-L (Fig. [4](#rjx218F4){ref-type="fig"}A) and remained unchanged (Fig. [4](#rjx218F4){ref-type="fig"}G). There was no intrahepatic bile duct injury. The trend was for increasing PAS staining over time (Fig. [4](#rjx218F4){ref-type="fig"}B, D, F and H).

![Representative histological samples to assess architectural integrity and necrosis by H&E staining (**A**, **C**, **E**, **G**) as well as glycogen content using Periodic acid-Schiff staining (**B**, **D**, **F**, **H**). Samples taken prior to commencement of NMP-L (A, B), after 3 h of NMP-L (C, D), after 6 h of NMP-L (E, F) and after parenchymal splitting with concurrent NMP-L (G, H).](rjx218f04){#rjx218F4}

DISCUSSION {#rjx218s8}
==========

This is the first study demonstrating that splitting a liver with concurrent NMP-L throughout is feasible and viability is maintained. Furthermore, this has been achieved in a liver unsuitable for transplantation. No studies to date have investigated liver splitting with concurrent NMP-L throughout splitting using either normothermic, subnormothermic or hypothermic strategies.

This technique presents advantages over existing methods. There is no increasing temperature and rewarming under ischaemic conditions seen with cold *ex situ* splitting. Whilst possible during *in situ* splitting, concurrent NMP-L provides *ex situ* direct visualization of perfused segments. Throughout splitting the cut surface can be inspected and vessels ligated to ensure haemostasis. Continuation of NMP-L permits continuous viability assessment. This may contribute to recipient selection, aid informed decision-making and facilitate logistics of transplanting two grafts by preventing long CIT. We have shown that *ex situ* splitting is feasible in ECD livers performed in combination with NMP-L, and results in pre-transplant biochemical, histological and Doppler findings that are compatible with transplantation.

Liver splitting during NMP-L has been described using the OrganOx® *metra™* device. Due to the closed circuit, a hanging procedure was implemented to facilitate dissection whilst minimizing fluid loss from the cut surface. Here perfusion was paused for 6 min to separate the grafts and yielded only an extended right segment still perfused \[[@rjx218C5]\]. Specific advantages of an open circuit include: superior manipulation; reduced risk of compromised flow; potential to perform and assess integrity of vascular reconstruction: the ability to perform the complete splitting procedure with concurrent NMP-L.

*Ex situ* splitting with NMP-L allows exploration of splitting ECD livers and may increase the donor pool enabling two recipients to be transplanted from a single donor, it could also facilitate training in liver splitting and provide controls for research.

Classical left lateral + right trisegmentectomy liver splitting with concurrent NMP-L is feasible, maintaining viability of both lobes, combining 'normal' physiological conditions and reduced CIT with the ease of *ex situ* splitting, without impacting on organ retrieval. Future work will allow improved monitoring and facilitate logistics.
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======================
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